Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Hepatitis

Free Subscription Articles published in PLoS One Retrieve available abstracts of 171 articles: HTML format

Single Articles

January 2025
1. TEPJANTA P, Saethang T, Fujiyama K, Misaki R, et al
   In vitro and in silico analyses of amino acid substitution effects at the conserved N-linked glycosylation site in hepatitis B virus surface protein on antigenicity, immunogenicity, HBV replication and secretion.
   PLoS One. 2025;20:e0316328.
   PubMed     Abstract available
   
   
   
2. MOONEN CPB, Brouwers EEHG, Hoebe CJPA, Dukers-Muijrers NHTM, et al
   Reaching Syrian migrants through Dutch municipal registries for hepatitis B and C point-of-care testing.
   PLoS One. 2025;20:e0316726.
   PubMed     Abstract available
   
   
   
3. ADJEI-GYAMFI S, Asirifi A, Asobuno C, Korang FK, et al
   Knowledge and occupational practices of beauticians and barbers in the transmission of viral hepatitis: A mixed-methods study in Volta Region of Ghana.
   PLoS One. 2025;20:e0306961.
   PubMed     Abstract available
   
   
   
4. PATIL A, Vidhate P, Patil S, Rao A, et al
   Looking back into the Hepatitis C Virus epidemic dynamics from Unnao, India through phylogenetic approach.
   PLoS One. 2025;20:e0317705.
   PubMed     Abstract available
   
   
   
5. TOY M, Hutton D, Conners EE, Pham H, et al
   Cost-effectiveness of monitoring and liver cancer surveillance among patients with inactive chronic hepatitis B.
   PLoS One. 2025;20:e0313898.
   PubMed     Abstract available
   
   
   
6. MUTAMBO IN, Bett B, Bukachi SA
   "Without a man's decision, nothing works": Building resilience to Rift Valley fever in pastoralist communities in Isiolo Kenya.
   PLoS One. 2025;20:e0316015.
   PubMed     Abstract available
   
   
   
7. KASONGAMULILO CC, Syakalima M, Saasa N, Kainga H, et al
   Evidence of human exposure and associated risk factors to Rift Valley fever in selected districts of Central and Western Zambia.
   PLoS One. 2025;20:e0309288.
   PubMed     Abstract available
   
   
   
8. ZUBAIR S, Parvaiz F, Abualait T, Al-Regaiey K, et al
   Computational design of multi-epitope vaccine against Hepatitis C Virus infection using immunoinformatics techniques.
   PLoS One. 2025;20:e0317520.
   PubMed     Abstract available
   
   
   
9. 
   Expression of Concern: Chaperone-Mediated Autophagy Targets IFNAR1 for Lysosomal Degradation in Free Fatty Acid Treated HCV Cell Culture.
   PLoS One. 2025;20:e0319262.
   PubMed    
   
   
   
10. YE W, Ding Y, Li M, Tian Z, et al
    Drug-induced autoimmune-like hepatitis: A disproportionality analysis based on the FAERS database.
    PLoS One. 2025;20:e0317680.
    PubMed     Abstract available
    
    
    
11. VAN RENNE N, Vanwolleghem T
    Detection of hepatitis B virus mRNA from single cell RNA sequencing data without prior knowledge.
    PLoS One. 2025;20:e0314060.
    PubMed     Abstract available
    
    
    
12. ELIAH DT, Chamba NG, Sadiq AM, Mwasamwaja AO, et al
    Seroprevalence and associated factors for hepatitis B and hepatitis C viral infection among patients with diabetes mellitus in Northern Tanzania.
    PLoS One. 2025;20:e0319198.
    PubMed     Abstract available
    
    
    
13. TORIU N, Sato Y, Kamimura H, Yoshikawa T, et al
    Aligning cellular and molecular components in age-dependent tertiary lymphoid tissues of kidney and liver.
    PLoS One. 2025;20:e0311193.
    PubMed     Abstract available
    
    
    
14. NOSAKA T, Naito T, Akazawa Y, Takahashi K, et al
    Identification of novel antiviral host factors by functional gene expression analysis using in vitro HBV infection assay systems.
    PLoS One. 2025;20:e0314581.
    PubMed     Abstract available
    
    
    
15. XUE M, Wu C, Liu K, Lu Q, et al
    Time series analysis and scaling law characteristics of viral hepatitis from 2004 to 2023 in Zhejiang Province, China.
    PLoS One. 2025;20:e0319642.
    PubMed     Abstract available
    
    
    
16. 
    Expression of Concern: Impaired expression of type I and type II interferon receptors in HCV-associated chronic liver disease and liver cirrhosis.
    PLoS One. 2025;20:e0320610.
    PubMed    
    
    
    
17. BERHANU L, Desye B, Daba C, Berihun G, et al
    Seroprevalence and risk factors of hepatitis B virus infection among healthcare workers in Africa: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0319986.
    PubMed     Abstract available
    
    
    
18. LAMICHHANE R, Pathak ID, Pathak BD, Adhikari P, et al
    Low Hepatitis B vaccination rates among medical students in South Asia: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0320330.
    PubMed     Abstract available
    
    
    
19. PAWLOWSKI T, Radkowski M, Perlejewski K, Szymanska B, et al
    Direct-acting antivirals (DAA) positively affect depression and cognitive function in patients with chronic hepatitis C.
    PLoS One. 2025;20:e0320221.
    PubMed     Abstract available
    
    
    
20. LI J, He J, Yang G, Cao Z, et al
    Influencing factors of HCV testing willingness among men who have sex with men in China: A structural equation modeling analysis.
    PLoS One. 2025;20:e0321469.
    PubMed     Abstract available
    
    
    
21. DAS N, Hossain MB, Adhikary A, Raha AD, et al
    Enlightened prognosis: Hepatitis prediction with an explainable machine learning approach.
    PLoS One. 2025;20:e0319078.
    PubMed     Abstract available
    
    
    
22. VO LT, Phan DQ, Tran HG, Nguyen LTP, et al
    Hepatitis B vaccine coverage in health care students: a cross-sectional study in Vietnam.
    PLoS One. 2025;20:e0320860.
    PubMed     Abstract available
    
    
    
23. BAKIC M, Stevanovic J, Milic M, Galic I, et al
    Factors associated with the prevalence of viral hepatitis B and C among prisoners: Results of two consecutive national surveys in Montenegro.
    PLoS One. 2025;20:e0321464.
    PubMed     Abstract available
    
    
    
24. OROTTA M, Munseri P, Massawe RV, Orotta GM, et al
    Hepatitis B virus: Prevalence, vaccination coverage and immune responses to immunization among healthcare workers at Muhimbili National Hospital.
    PLoS One. 2025;20:e0321623.
    PubMed     Abstract available
    
    
    
25. FOSU PK, Hoor GT, Adjei CA, Atibila F, et al
    Prevalence of Hepatitis C viral infection in Ghana: A systematic review and meta-analysis protocol.
    PLoS One. 2025;20:e0321483.
    PubMed     Abstract available
    
    
    
26. AWADELKARIM KE, Osman NAM, Eleragi AMS, Nail AMA, et al
    Chronic active and chronic inactive hepatitis B virus infection: Comparative study of genetic polymorphism and blood profile measures.
    PLoS One. 2025;20:e0322268.
    PubMed     Abstract available
    
    
    
27. NAMATOVU J, Lule P, Asindu M, Campbell ZA, et al
    Gender roles in ruminant disease management in Uganda: Implications for the control of peste des petits ruminants and Rift Valley fever.
    PLoS One. 2025;20:e0320991.
    PubMed     Abstract available
    
    
    
28. BAHARUDIN MH, Mokhtar SA, Azman AZF, Mohd Nazan AIN, et al
    Utilizing Theory of Planned Behaviour to increase intention to participate in hepatitis C treatment therapy among Methadone maintenance therapy clients (MMT) in Malaysia: A cluster randomised control trial.
    PLoS One. 2025;20:e0324718.
    PubMed     Abstract available
    
    
    
29. SEGHIERI C, Ceccarelli L, Tortu C, Tavoschi L, et al
    Evaluating the effectiveness of a population-level health intervention to increment HCV treatment coverage in tuscany region, Italy: An interrupted time series analysis.
    PLoS One. 2025;20:e0306733.
    PubMed     Abstract available
    
    
    
30. CAM HUONG NT, Van Tri D, Luan NH, Thinh NH, et al
    Seroprevalence of hepatitis A virus infection in urban and rural areas in Vietnam.
    PLoS One. 2025;20:e0323139.
    PubMed     Abstract available
    
    
    
31. BHAT KD, Bhattacharya H, Jayaraman Y, Kanungo S, et al
    Hepatitis B virus infection among children aged 1- 5 years of Mayurbhanj district (Odisha), India: A prospective study protocol.
    PLoS One. 2025;20:e0317621.
    PubMed     Abstract available
    
    
    
32. ASSOAH E, Yar DD, Amissah-Reynolds PK, Balali GI, et al
    Co-infections and risk factors of Toxoplasma gondii infection among pregnant women in Ghana: A facility-based cross-sectional study.
    PLoS One. 2025;20:e0324950.
    PubMed     Abstract available
    
    
    
33. PRAGUYLERTLUCK W, Kaewdech A, Chamroonkul N, Piratvisuth T, et al
    Effect of switching from prior Nucleos(t)ide Analogue(s) to Tenofovir alafenamide on lipid profile and cardiovascular risk in patients with Chronic Hepatitis B.
    PLoS One. 2025;20:e0324897.
    PubMed     Abstract available
    
    
    
34. WOYTOWICH D, McIntyre AF, Solomon H, Hanunka B, et al
    Local data for local programming: Results from an HIV biobehavioral survey among people who inject drugs in Livingstone, Lusaka, and Ndola, Zambia, 2021.
    PLoS One. 2025;20:e0323919.
    PubMed     Abstract available
    
    
    
35. MOTSHOSI P, Phinius BB, Jongman M, Baruti K, et al
    Optimization of dried blood spot for hepatitis B virus surface antibody quantification.
    PLoS One. 2025;20:e0304931.
    PubMed     Abstract available
    
    
    
36. MA X, Huang T, Song Y, Pan H, et al
    Bioinformatics and system biology approach to discover the common pathogenetic processes between COVID-19 and chronic hepatitis B.
    PLoS One. 2025;20:e0323708.
    PubMed     Abstract available
    
    
    
37. KERR CM, Proctor-Roser MA, Parthasarathy S, O'Connor JJ, et al
    IFN-gamma signaling is required for the efficient replication of murine hepatitis virus (MHV) strain JHM in the brains of infected mice.
    PLoS One. 2025;20:e0317482.
    PubMed     Abstract available
    
    
    
38. PARK YJ, Yi KY, Woo HY, Heo J, et al
    Risk of HBV reactivation in HBV/HCV-co-infected HCV-treated patients: A single-center study.
    PLoS One. 2025;20:e0324019.
    PubMed     Abstract available
    
    
    
39. CEPEDA J, Atta M, Zook K, Landry M, et al
    Longitudinal effect of HCV cure on markers of kidney disease.
    PLoS One. 2025;20:e0325699.
    PubMed     Abstract available
    
    
    
40. ZHANG J, Cao Y, Jin Z, A R, et al
    Dynamic CYP2E1 expression and metabolic activity changes in male rats during immune liver injury and sex differences in alcohol metabolism.
    PLoS One. 2025;20:e0325135.
    PubMed     Abstract available
    
    
    
41. LIN X, Gong L, Gou Y, Liu Y, et al
    High prevalence of Duck Hepatitis B virus-associated coinfection in Southwest China.
    PLoS One. 2025;20:e0324682.
    PubMed     Abstract available
    
    
    
42. ZHONG J, Li Y, Liu Y, Qiao J, et al
    Hepatitis B virus X protein (HBx)-mediated immune modulation and prognostic model development in hepatocellular carcinoma.
    PLoS One. 2025;20:e0325363.
    PubMed     Abstract available
    
    
    
43. TUSHER EH, Ismail MA, Akib A, Gabralla LA, et al
    Comparative investigation of bagging enhanced machine learning for early detection of HCV infections using class imbalance technique with feature selection.
    PLoS One. 2025;20:e0326488.
    PubMed     Abstract available
    
    
    
44. HAGE K, Hamusonde K, van Santen DK, Newsum AM, et al
    Longitudinal trajectories of sexual behavior and incident hepatitis C reinfection among men who have sex with men with HIV.
    PLoS One. 2025;20:e0326094.
    PubMed     Abstract available
    
    
    
45. BUTI M, Cabezas J, Dominguez-Hernandez R, Cantero H, et al
    Socioeconomic impact of chronic delta hepatitis in Spain: Indirect costs of work absenteeism, presenteeism, and premature mortality.
    PLoS One. 2025;20:e0324834.
    PubMed     Abstract available
    
    
    
46. EBERWEIN AE, Cummings PR, Cummings D, Andre J, et al
    Hepatitis B (HBsAg) prevalence among obstetric patients in Caluquembe, Angola, 2023-2024.
    PLoS One. 2025;20:e0327426.
    PubMed     Abstract available
    
    
    
47. ODINOH R, Dawa J, Situma S, Nyakarahuka L, et al
    Have you heard of Rift Valley fever? Findings from a multi-country study in East and Central Africa.
    PLoS One. 2025;20:e0327398.
    PubMed     Abstract available
    
    
    
48. SILVA FILHO GFD, Milhomem AB, Diniz E Silva BV, Santos KCD, et al
    Taking the opportunity of COVID testing to screen vulnerable populations for hepatitis B, hepatitis C, syphilis, and human immunodeficiency virus in Central Brazil.
    PLoS One. 2025;20:e0325859.
    PubMed     Abstract available
    
    
    
49. LIN Y, Lin X, Xia R, Chen J, et al
    Tenofovir alafenamide is superior to tenofovir disoproxil fumarate and entecavir in cost-effectiveness of treatment of chronic hepatitis B in china with new volume-based procurement policy.
    PLoS One. 2025;20:e0327298.
    PubMed     Abstract available
    
    
    
50. TORGERSEN J, Newcomb CW, Carbonari DM, Smith SM, et al
    Magnetic resonance evaluation of three-dimensional liver fat fraction by hepatitis C status and associations with inflammatory cytokines.
    PLoS One. 2025;20:e0327668.
    PubMed     Abstract available
    
    
    
51. MILLER LS, Rao A, Tunnell K, Wang YF, et al
    Independent assessment of a point of care HCV RNA test by laboratory analytical testing and a prospective field study in the U.S.
    PLoS One. 2025;20:e0324088.
    PubMed     Abstract available
    
    
    
52. LIM J, Kim YJ, Kim S, Shim JH, et al
    Impact of metabolic dysfunction-associated steatotic liver disease on hepatocellular carcinoma risk in autoimmune hepatitis.
    PLoS One. 2025;20:e0325066.
    PubMed     Abstract available
    
    
    
53. ZENG D, Wang S, Cheng N, Li B, et al
    Exploring the combined impact of hepatitis B antibody status and systemic immune-inflammation index on mortality risk: A population-based study.
    PLoS One. 2025;20:e0328400.
    PubMed     Abstract available
    
    
    
54. DUO H, You J, Du S, Yu M, et al
    Liver cirrhosis in 2021: Global Burden of Disease study.
    PLoS One. 2025;20:e0328493.
    PubMed     Abstract available
    
    
    
55. NJAU AF, Robert M, Rwebembera A, Kisendi R, et al
    Prevalence and associated factors for HIV, HBV and syphilis coinfections among pregnant women attending antenatal care in Tanzania.
    PLoS One. 2025;20:e0329068.
    PubMed     Abstract available
    
    
    
56. MUPEDZA TV, Mhlanga L, Mamutse D, Helikumi M, et al
    Modeling the effects of treatment adherence challenges on the transmission dynamics of hepatitis C virus.
    PLoS One. 2025;20:e0329543.
    PubMed     Abstract available
    
    
    
57. NYGARD ODEH K, Soloy Nilsen H, Gangsoy Kristiansen M, Brekke OL, et al
    Cytokines interferon-gamma- inducible protein 10 and granulocyte-macrophage colony-stimulating factor are associated with psychiatric symptoms in opioid-dependent patients: A cross- sectional study.
    PLoS One. 2025;20:e0324365.
    PubMed     Abstract available
    
    
    
58. NGUYEN HTT, Lee HS, Bett B, Ling J, et al
    Seroprevalence and risk factors of hantavirus and hepatitis E virus exposure among wildlife farmers in Vietnam.
    PLoS One. 2025;20:e0329570.
    PubMed     Abstract available
    
    
    
59. KHOUNVISITH V, Virachith S, Innoula N, Khenkha L, et al
    Seroprevalence of antibodies against hepatitis A and E among the general population in 5 provinces, Lao People's Democratic Republic: Variation according to location.
    PLoS One. 2025;20:e0329384.
    PubMed     Abstract available
    
    
    
60. SHEWAYE AB, Berhane KA, Fanta AD
    Hepatitis A beyond childhood causing diagnostic and therapeutic challenges in Addis Ababa, Ethiopia.
    PLoS One. 2025;20:e0330212.
    PubMed     Abstract available
    
    
    
61. META-DJOMSI D, Atsama-Amougou M, Ngamaleu MR, Godwe C, et al
    Molecular surveillance of hepatitis E virus in wastewater in Yaounde, Cameroon.
    PLoS One. 2025;20:e0322765.
    PubMed     Abstract available
    
    
    
62. JIN Y, Lu R, Wang M, Xu Z, et al
    Analysis of blood screening strategies and their efficacy among voluntary blood donors in a region of East China.
    PLoS One. 2025;20:e0331027.
    PubMed     Abstract available
    
    
    
63. SONG J, Choi SJ, Kim S, Park Y, et al
    Comparative evaluation of four fully automated immunoanalyzers for the simultaneous detection of HBeAg and Anti-HBe.
    PLoS One. 2025;20:e0331381.
    PubMed     Abstract available
    
    
    
64. QI X, Hu Y, Jiang W
    Epidemiological trends and projections to 2035 of hepatitis B burden in China, 1990-2021.
    PLoS One. 2025;20:e0330633.
    PubMed     Abstract available
    
    
    
65. HAN L, Bi L, Li X
    The diagnostic value of decreased levels of inflammatory markers for the state of hepatitis C virus (HCV) infection.
    PLoS One. 2025;20:e0332105.
    PubMed     Abstract available
    
    
    
66. WAGI CR, McDowell R, Wright A, Egan KL, et al
    Navigating Hepatitis C care: Knowledge gaps and access barriers among young women who inject drugs in rural Appalachia.
    PLoS One. 2025;20:e0331849.
    PubMed     Abstract available
    
    
    
67. SHENGELAIA L, Anderson EJ, Butsashvili M, Gulbiani L, et al
    Hepatitis C virus reinfection among people who inject drugs in the country of Georgia and injection-related risk factors: Implications for HCV elimination in the EECA region.
    PLoS One. 2025;20:e0330764.
    PubMed     Abstract available
    
    
    
68. CHEN L, Lu Z, Zhang X, Lai J, et al
    Risk of hepatitis B virus reactivation in the treatment of HBsAg and HBV DNA double-negative lymphoma patients.
    PLoS One. 2025;20:e0332421.
    PubMed     Abstract available
    
    
    
69. ADJEI-ROGER J, Afagbedzi S, Tei-Maya E, Guure C, et al
    Evaluation of statistical regression models in predicting factors influencing HBV and HIV among female sex workers in Ghana: A Bio-behavioural survey.
    PLoS One. 2025;20:e0332152.
    PubMed     Abstract available
    
    
    
70. DOMINGUEZ A, Torner N, Soldevila N, Varela C, et al
    Hepatitis A in Spain: Evolution of hospitalization in the period 2000-2021.
    PLoS One. 2025;20:e0332317.
    PubMed     Abstract available
    
    
    January 2024
71. DARVISHI-KHEZRI H, Karami H, Naderisorki M, Ghazaiean M, et al
    Two risk factors for hypozincemia in diabetic beta-thalassemia patients: Hepatitis C and deferasirox.
    PLoS One. 2024;19:e0284267.
    PubMed     Abstract available
    
    
    
72. HOSKING K, De Santis T, Vintour-Cesar E, Wilson PM, et al
    "Putting the power back into community": A mixed methods evaluation of a chronic hepatitis B training course for the Aboriginal health workforce of Australia's Northern Territory.
    PLoS One. 2024;19:e0288577.
    PubMed     Abstract available
    
    
    
73. SHIBABAW AA, Tegegne MD, Walle AD, Wubante SM, et al
    Information seeking behavior on hepatitis B virus, and its associated factors among pregnant women at teaching and specialized hospitals, Northwest Ethiopia: A cross-sectional study.
    PLoS One. 2024;19:e0286755.
    PubMed     Abstract available
    
    
    
74. KALIBATAS V, Kalibatiene L, Imashpayev D
    Blood donations and donors' profile in Lithuania: Trends for coming back after the COVID-19 outbreak.
    PLoS One. 2024;19:e0297580.
    PubMed     Abstract available
    
    
    
75. KENFACK-MOMO R, Ngounoue MD, Kenmoe S, Takuissu GR, et al
    Global epidemiology of hepatitis C virus in dialysis patients: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0284169.
    PubMed     Abstract available
    
    
    
76. MODIYINJI AF, Tankeu LTA, Monamele CG, Yifomnjou Moumbeket MH, et al
    Hepatitis E virus infections among patients with acute febrile jaundice in two regions of Cameroon: First molecular characterization of hepatitis E virus genotype 4.
    PLoS One. 2024;19:e0298723.
    PubMed     Abstract available
    
    
    
77. ABER JO, Bongomin F, Opio SL, Ochola E, et al
    Hepatitis B vaccine uptake and associated factors among adults of Gulu city in Northern Uganda: A community-based cross-sectional study.
    PLoS One. 2024;19:e0297617.
    PubMed     Abstract available
    
    
    
78. DZUDZOR B, Nsowah KK, Agyemang S, Vento S, et al
    Overt and occult hepatitis B virus infection detected among chronic kidney disease patients on haemodialysis at a Tertiary Hospital in Ghana.
    PLoS One. 2024;19:e0290917.
    PubMed     Abstract available
    
    
    
79. CAMA E, Brener L, Broady T, Horwitz R, et al
    Hepatitis B screening and knowledge among Chinese and Vietnamese students in Australia.
    PLoS One. 2024;19:e0299224.
    PubMed     Abstract available
    
    
    
80. NOMBOT-YAZENGUET MPM, Modiyinji AF, Tricou V, Manirakiza A, et al
    Investigating animal reservoirs for hepatitis E virus in Bangui, Central African Republic.
    PLoS One. 2024;19:e0300608.
    PubMed     Abstract available
    
    
    
81. YEN YH, Kee KM, Hu TH, Tsai MC, et al
    Hepatitis B virus-related hepatocellular carcinoma has superior overall survival compared with other etiologies.
    PLoS One. 2024;19:e0290523.
    PubMed     Abstract available
    
    
    
82. TEPJANTA P, Fujiyama K, Misaki R, Kimkong I, et al
    The N-linked glycosylation modifications in the hepatitis B surface protein impact cellular autophagy, HBV replication, and HBV secretion.
    PLoS One. 2024;19:e0299403.
    PubMed     Abstract available
    
    
    
83. VECHI HT, Bay MB, Freitas CHS, Sant'anna JGFC, et al
    Factors associated with hepatitis A susceptibility among men who have sex with men using HIV pre-exposure prophylaxis in Northeastern Brazil: A cross-sectional study.
    PLoS One. 2024;19:e0301397.
    PubMed     Abstract available
    
    
    
84. DEBSIKREO N, Mankreo BL, Moukenet A, Ouangkake M, et al
    Prevalence of hepatitis B virus infection and its associated factors among students in N'Djamena, Chad.
    PLoS One. 2024;19:e0273589.
    PubMed     Abstract available
    
    
    
85. TADESSE K, Ayalew G, Million Y, Gelaw A, et al
    Hepatitis B and hepatitis C virus infections and associated factors among prisoners in Gondar City, Northwest Ethiopia.
    PLoS One. 2024;19:e0301973.
    PubMed     Abstract available
    
    
    
86. SENOO-DOGBEY VE, Anto F, Quansah R, Danso-Appiah A, et al
    Completion of three-dose hepatitis B vaccination cycle and associated factors among health care workers in the Greater Accra Region of Ghana.
    PLoS One. 2024;19:e0298771.
    PubMed     Abstract available
    
    
    
87. DUCHEN D, Clipman SJ, Vergara C, Thio CL, et al
    A hepatitis B virus (HBV) sequence variation graph improves alignment and sample-specific consensus sequence construction.
    PLoS One. 2024;19:e0301069.
    PubMed     Abstract available
    
    
    
88. KIMBALL S, Reynoso M, McKnight C, Des Jarlais D, et al
    Hepatitis C treatment outcomes among people who inject drugs experiencing unstable versus stable housing: Systematic review and meta-analysis.
    PLoS One. 2024;19:e0302471.
    PubMed     Abstract available
    
    
    
89. WENDELBOE AM, Naqvi OH, Williams M, Hollen H, et al
    Opioid and other drug use and drug-related mortality as indicators of Hepatitis C and Human Immunodeficiency Virus in Oklahoma.
    PLoS One. 2024;19:e0301442.
    PubMed     Abstract available
    
    
    
90. BASIMANE-BISIMWA P, Koyaweda GW, Ngaiganam E, Vickos U, et al
    Seroprevalence and molecular characterization of viral hepatitis and HIV co-infection in the Central African Republic.
    PLoS One. 2024;19:e0291155.
    PubMed     Abstract available
    
    
    
91. ANANCHUENSOOK P, Suksawatamnauy S, Thaimai P, Sriphoosanaphan S, et al
    Correction: The association between vitamin D receptor polymorphism and phases of chronic hepatitis B infection in HBV carriers in Thailand.
    PLoS One. 2024;19:e0303545.
    PubMed     Abstract available
    
    
    
92. HAGOS YM, Yalew GT, Meles HN, Tsegay E, et al
    Hepatitis B and C viral coinfection and associated factors among HIV-positive patients attending ART clinics of Afar regional state, northeast Ethiopia.
    PLoS One. 2024;19:e0302453.
    PubMed     Abstract available
    
    
    
93. GOLAM RM, Khalil MAF, Shaker OG, Ahmed TI, et al
    The clinical significance of long non-coding RNAs MALAT1 and CASC2 in the diagnosis of HCV-related hepatocellular carcinoma.
    PLoS One. 2024;19:e0303314.
    PubMed     Abstract available
    
    
    
94. PEWKLIANG Y, Thongsri P, Suthivanich P, Thongbaiphet N, et al
    Immortalized hepatocyte-like cells: A competent hepatocyte model for studying clinical HCV isolate infection.
    PLoS One. 2024;19:e0303265.
    PubMed     Abstract available
    
    
    
95. MIURA M, Nishino M, Kawaguchi K, Li S, et al
    Programmed cell death-1 is involved with peripheral blood immune cell profiles in patients with hepatitis C virus antiviral therapy.
    PLoS One. 2024;19:e0299424.
    PubMed     Abstract available
    
    
    
96. WANG L, Liao F, Yang L, Jiang L, et al
    KLRG1-expressing CD8+ T cells are exhausted and polyfunctional in patients with chronic hepatitis B.
    PLoS One. 2024;19:e0303945.
    PubMed     Abstract available
    
    
    
97. GEDEFIE A, Debash H, Asmamaw S, Getaneh FB, et al
    Epidemiology of an overlapping and parallel infection of Sexually Transmitted Infections among pregnant women in North-east Ethiopia: Its implication for prevention of mother to child transmission.
    PLoS One. 2024;19:e0300149.
    PubMed     Abstract available
    
    
    
98. SABIN L, Haghparast-Bidgoli H, Miller F, Saville N, et al
    A systematic review of barriers and facilitators to antenatal screening for HIV, syphilis or hepatitis B in Asia: Perspectives of pregnant women, their relatives and health care providers.
    PLoS One. 2024;19:e0300581.
    PubMed     Abstract available
    
    
    
99. PULLARKAT S, Black G, Bleakley M, Buenrostro D, et al
    qPCR assay for detection of Woodchuck Hepatitis Virus Post-Transcriptional Regulatory Elements from CAR-T and TCR-T cells in fresh and formalin-fixed tissue.
    PLoS One. 2024;19:e0303057.
    PubMed     Abstract available
    
    
    
100. HAN J, Jang KL
     All-trans retinoic acid downregulates HBx levels via E6-associated protein-mediated proteasomal degradation to suppress hepatitis B virus replication.
     PLoS One. 2024;19:e0305350.
     PubMed     Abstract available
     
     
     
101. CHI G, Pei J, Li X
     Inflammatory bowel disease and risk of autoimmune hepatitis: A univariable and multivariable Mendelian randomization study.
     PLoS One. 2024;19:e0305220.
     PubMed     Abstract available
     
     
     
102. SALU OB, Akinbamiro TF, Orenolu RM, Ishaya OD, et al
     Detection of hepatitis viruses in suspected cases of Viral Haemorrhagic Fevers in Nigeria.
     PLoS One. 2024;19:e0305521.
     PubMed     Abstract available
     
     
     
103. NDZIE ONDIGUI JL, Mafopa Goumkwa N, Lobe C, Wandji B, et al
     Prevalence and risk factors of transmission of hepatitis delta virus in pregnant women in the Center Region of Cameroon.
     PLoS One. 2024;19:e0287491.
     PubMed     Abstract available
     
     
     
104. GURAV YK, Bagepally BS, Chitpim N, Sobhonslidsuk A, et al
     Cost-effective analysis of hepatitis A vaccination in Kerala state, India.
     PLoS One. 2024;19:e0306293.
     PubMed     Abstract available
     
     
     
105. FARHAN M, Shah Z, Ling Z, Shah K, et al
     Global dynamics and computational modeling for analyzing and controlling Hepatitis B: A novel epidemic approach.
     PLoS One. 2024;19:e0304375.
     PubMed     Abstract available
     
     
     
106. NAM DE, Park SJ, Omole S, Um E, et al
     Activated Gab1 drives hepatocyte proliferation and anti-apoptosis in liver fibrosis via potential involvement of the HGF/c-Met signaling axis.
     PLoS One. 2024;19:e0306345.
     PubMed     Abstract available
     
     
     
107. SALIA E, Nartey YA, Djankpa FT, Pappoe F, et al
     Prevalence of occult hepatitis B infection among treatment-naive persons living with HIV in Ghana.
     PLoS One. 2024;19:e0305862.
     PubMed     Abstract available
     
     
     
108. ZEZIULIN O, Kornilova M, Deac A, Morozova O, et al
     Modes of HIV transmission among young women and their sexual partners in Ukraine.
     PLoS One. 2024;19:e0305072.
     PubMed     Abstract available
     
     
     
109. BASIMANE BISIMWA P, Koyaweda GW, Bihehe Masemo D, Ayagirwe RBB, et al
     High prevalence of hepatitis B and HIV among women survivors of sexual violence in South Kivu province, eastern Democratic Republic of Congo.
     PLoS One. 2024;19:e0292473.
     PubMed     Abstract available
     
     
     
110. SIAW ADJ, Amugsi J, Owusu-Konadu MAA, Drah ST, et al
     Prevalence and risk factors of Hepatitis C virus infection in the Upper East Region of Ghana; a community-based cross-sectional study.
     PLoS One. 2024;19:e0306292.
     PubMed     Abstract available
     
     
     
111. YIRSAW BG, Agimas MC, Alemu GG, Tesfie TK, et al
     Prevalence of Hepatitis B virus infection and its determinants among pregnant women in East Africa: Systematic review and Meta-analysis.
     PLoS One. 2024;19:e0307102.
     PubMed     Abstract available
     
     
     
112. GIKUNYU CW, Mbogori E, Kwena A, Maiyoh GK, et al
     Prevalence of HBV genotypes among patients attending Moi Teaching and Referral Hospital liver clinic.
     PLoS One. 2024;19:e0305753.
     PubMed     Abstract available
     
     
     
113. KITIL GW, Dubale AT, Shibabaw AA, Chereka AA, et al
     Practices for preventing Hepatitis B infection among health science students in Ethiopia: Systematic review and meta-analysis.
     PLoS One. 2024;19:e0306965.
     PubMed     Abstract available
     
     
     
114. YOUNES N, Chemaitelly H, Nizamuddin PB, Al-Hamad T, et al
     Prevalence of hepatitis A virus among migrant workers in Qatar: A national study.
     PLoS One. 2024;19:e0306753.
     PubMed     Abstract available
     
     
     
115. ZEHRA A, Jamil S, Farman M, Nisar KS, et al
     Modeling and analysis of Hepatitis B dynamics with vaccination and treatment with novel fractional derivative.
     PLoS One. 2024;19:e0307388.
     PubMed     Abstract available
     
     
     
116. LAREBO YM, Anshebo AA, Abdo RA, Behera SK, et al
     Prevalence of hepatitis B virus infection among pregnant women in Africa: A systematic review and meta-analysis.
     PLoS One. 2024;19:e0305838.
     PubMed     Abstract available
     
     
     
117. ATANAW T, Girmay G, Zemene A, Assefa M, et al
     Seroprevalence of hepatitis B and C viruses and some possible associated factors among cancer patients at the Oncology Treatment Center, Gondar, Northwest Ethiopia: A cross-sectional study.
     PLoS One. 2024;19:e0308161.
     PubMed     Abstract available
     
     
     
118. ANTENEH DE, Taye EB, Seyoum AT, Abuhay AE, et al
     Seroprevalence of HIV, HBV, and syphilis co-infections and associated factors among pregnant women attending antenatal care in Amhara regional state, northern Ethiopia: A hospital-based cross-sectional study.
     PLoS One. 2024;19:e0308634.
     PubMed     Abstract available
     
     
     
119. 
     Retraction: Interferon and Ribavirin Combination Treatment Synergistically Inhibit HCV Internal Ribosome Entry Site Mediated Translation at the Level of Polyribosome Formation.
     PLoS One. 2024;19:e0308579.
     PubMed    
     
     
     
120. DANIELS J, Nartey YA, Djankpa F, Simpore J, et al
     Characteristics and antiviral treatment eligibility of patients diagnosed with hepatitis B at a teaching hospital in Ghana: Implications for prevention and management.
     PLoS One. 2024;19:e0302086.
     PubMed     Abstract available
     
     
     
121. KIM N, Kim S, Choi JR, Park Y, et al
     Evaluation of autoimmune liver disease antibodies in hepatitis patients.
     PLoS One. 2024;19:e0307285.
     PubMed     Abstract available
     
     
     
122. DOS MUCHANGOS V, Chambal L, Nilsson C, Sevene E, et al
     HIV and hepatitis B virus co-infection in Mozambique: Policy review and health professionals' knowledge and practices.
     PLoS One. 2024;19:e0301305.
     PubMed     Abstract available
     
     
     
123. MANGALA C, Maulot-Bangola D, Moutsinga A, Okolongo-Mayani SC, et al
     Prevalence and factors associated with transfusion-transmissible infections (HIV, HBV, HCV and Syphilis) among blood donors in Gabon: Systematic review and meta-analysis.
     PLoS One. 2024;19:e0307101.
     PubMed     Abstract available
     
     
     
124. LEE CSJ, Mateu-Gelabert P, Melendez YA, Fong C, et al
     Reduced injection risk behavior with co-located hepatitis C treatment at a syringe service program: The accessible care model.
     PLoS One. 2024;19:e0308102.
     PubMed     Abstract available
     
     
     
125. GUURE C, Dery S, Baptista da Silva C, Asamoah-Adu C, et al
     Situational assessment and epidemiology of HIV, HBV and HCV among people who use and inject drugs in Ghana.
     PLoS One. 2024;19:e0305923.
     PubMed     Abstract available
     
     
     
126. KIM MN, Kim BK, Cho H, Goh MJ, et al
     Similar recurrence after curative treatment of HBV-related HCC, regardless of HBV replication activity.
     PLoS One. 2024;19:e0307712.
     PubMed     Abstract available
     
     
     
127. MAZUMDER H, Hossain MF, Shrestha P, Mahmud S, et al
     Prevalence and associated risk factors of current hepatitis C infection among U.S. general population and injection drug users aged 20-59 years: NHANES 2009-2018.
     PLoS One. 2024;19:e0309345.
     PubMed     Abstract available
     
     
     
128. WANG HW, Wang YC, Huang YT, Jiang MY, et al
     All-cause and cause-specific mortality risk among men and women with hepatitis C virus infection.
     PLoS One. 2024;19:e0309819.
     PubMed     Abstract available
     
     
     
129. LU Y, Mohammad NS, Lee J, Aranyos AM, et al
     Berberine potentiates liver inflammation and fibrosis in the PI*Z hAAT transgenic murine model.
     PLoS One. 2024;19:e0310524.
     PubMed     Abstract available
     
     
     
130. PHYO Z, Ko K, Ouoba S, Sugiyama A, et al
     Intermediate hepatitis C virus (HCV) endemicity and its genotype distribution in Myanmar: A systematic review and meta-analysis.
     PLoS One. 2024;19:e0307872.
     PubMed     Abstract available
     
     
     
131. CHIU I, Cano D, Leathers M, Turner CM, et al
     HIV and hepatitis C virus infection and co-infection among trans women in San Francisco, 2020.
     PLoS One. 2024;19:e0307990.
     PubMed     Abstract available
     
     
     
132. MLEWA M, Nyawale HA, Henerico S, Mangowi I, et al
     Hepatitis B infection: Evaluation of demographics and treatment of chronic hepatitis B infection in Northern-western Tanzania.
     PLoS One. 2024;19:e0309314.
     PubMed     Abstract available
     
     
     
133. MULLER DL, Stuckey H, Flores ES, Wang L, et al
     Primary care physicians' perspectives on adults with diabetes and the recommended hepatitis B vaccine: A qualitative study.
     PLoS One. 2024;19:e0312168.
     PubMed     Abstract available
     
     
     
134. ALARIDAH N, Jereisat RA, Abu-Mutaw S, Abuhani HO, et al
     Knowledge, attitude, and practices toward Hepatitis B infection among hemodialysis patients: A nationwide study in Jordan.
     PLoS One. 2024;19:e0312226.
     PubMed     Abstract available
     
     
     
135. MBENCHO MN, Hafza N, Cao LC, Mingo VN, et al
     Incidence of Occult Hepatitis B Infection (OBI) and hepatitis B genotype characterization among blood donors in Cameroon.
     PLoS One. 2024;19:e0312126.
     PubMed     Abstract available
     
     
     
136. ASTLEY J, Saralamba S, Poovorawan K, White LJ, et al
     Population and transmission dynamics model to determine WHO targets for eliminating Hepatitis C virus in Thailand.
     PLoS One. 2024;19:e0309313.
     PubMed     Abstract available
     
     
     
137. PASTOR F, Charles E, Di Vona C, Chapelle M, et al
     The dual-specificity kinase DYRK1A interacts with the Hepatitis B virus genome and regulates the production of viral RNA.
     PLoS One. 2024;19:e0311655.
     PubMed     Abstract available
     
     
     
138. EBRAHIMI R, Masouri MM, Salehi Amniyeh Khozani AA, Ramadhan Hussein D, et al
     Safety and efficacy of fecal microbiota transplantation for viral diseases: A systematic review of clinical trials.
     PLoS One. 2024;19:e0311731.
     PubMed     Abstract available
     
     
     
139. 
     Retraction: SH2 Modified STAT1 Induces HLA-I Expression and Improves IFN-gamma Signaling in IFN-alpha Resistant HCV Replicon Cells.
     PLoS One. 2024;19:e0313111.
     PubMed    
     
     
     
140. JIANG J, Shiels MS, Rivera D, Ghany MG, et al
     Trends in hepatocellular carcinoma and viral hepatitis treatment in older Americans.
     PLoS One. 2024;19:e0307746.
     PubMed     Abstract available
     
     
     
141. ONDONDO RO, Muthusi J, Oramisi V, Kimani D, et al
     Prevalence of hepatitis B virus infection in Kenya: A study nested in the Kenya Population-based HIV Impact Assessment 2018.
     PLoS One. 2024;19:e0310923.
     PubMed     Abstract available
     
     
     
142. ZHANG C, Ma Q, Wang W, Song H, et al
     Increased QPCT gene expression by the hepatitis B virus promotes HBV replication.
     PLoS One. 2024;19:e0312773.
     PubMed     Abstract available
     
     
     
143. GIRMAY G, Bewket G, Amare A, Angelo AA, et al
     Seroprevalence of viral hepatitis B and C infections among healthcare workers in Ethiopia: A systematic review and meta-analysis.
     PLoS One. 2024;19:e0312959.
     PubMed     Abstract available
     
     
     
144. KANOKUDOM S, Poovorawan K, Nilyanimit P, Suntronwong N, et al
     Comparison of anti-HCV combined with HCVcAg (Elecsys HCV Duo immunoassay) and anti-HCV rapid test followed by HCV RNA analysis using qRT-PCR to identify active infection for treatment.
     PLoS One. 2024;19:e0313771.
     PubMed     Abstract available
     
     
     
145. LAMICHHANE R, Adhikari P, Pathak BD, Rai A, et al
     Knowledge, attitude, and practice towards Hepatitis B and vaccination status of pre-clinical medical students at Sylhet Women's Medical College, Bangladesh.
     PLoS One. 2024;19:e0310443.
     PubMed     Abstract available
     
     
     
146. SHAN J, Huang B, Xin Y, Li R, et al
     The clinical characteristics and SARS-CoV-2 infection in children of acute hepatitis with unknown aetiology: A meta-analysis and systematic review.
     PLoS One. 2024;19:e0311772.
     PubMed     Abstract available
     
     
     
147. NAULLY PG, Tan MI, Nugrahapraja H, Artarini AA, et al
     Design of multi-epitope-based therapeutic vaccine candidates from HBc and HBx proteins of hepatitis B virus using reverse vaccinology and immunoinformatics approaches.
     PLoS One. 2024;19:e0313269.
     PubMed     Abstract available
     
     
     
148. HONGJAISEE S, Khamduang W, Kham-Kjing N, Ngo-Giang-Huong N, et al
     Seroprevalence and associated factors of HIV, syphilis, hepatitis B, and hepatitis C infections among sex workers in Chiangmai, Thailand during easing of COVID-19 lockdown measures.
     PLoS One. 2024;19:e0316668.
     PubMed     Abstract available
     
     
     January 2023
149. EJAZ S, Paracha RZ, Ejaz S, Jamal Z, et al
     Antibody designing against IIIabc junction (JIIIabc) of HCV IRES through affinity maturation; RNA-Antibody docking and interaction analysis.
     PLoS One. 2023;18:e0291213.
     PubMed     Abstract available
     
     
     
150. YOSHIDA Y, Atsukawa M, Kondo C, Kitamura M, et al
     A novel formula used for predicting hepatocellular carcinoma after the achievement of sustained virologic response by direct-acting antivirals in patients with chronic hepatitis C.
     PLoS One. 2023;18:e0292019.
     PubMed     Abstract available
     
     
     
151. ZHANG Z, Liang G, Chang K
     Stationary distribution of a reaction-diffusion hepatitis B virus infection model driven by the Ornstein-Uhlenbeck process.
     PLoS One. 2023;18:e0292073.
     PubMed     Abstract available
     
     
     
152. 
     Expression of Concern: The HBx Oncoprotein of Hepatitis B Virus Deregulates the Cell Cycle by Promoting the Intracellular Accumulation and Re-Compartmentalization of the Cellular Deubiquitinase USP37.
     PLoS One. 2023;18:e0293102.
     PubMed    
     
     
     
153. BEDASSA BB, Ebo GG, Yimam JA, Tura JB, et al
     Correction: Prevalence and factors associated with hepatitis B and C virus infections among female Sex workers in Ethiopia: Results of the national biobehavioral Survey, 2020.
     PLoS One. 2023;18:e0292824.
     PubMed     Abstract available
     
     
     
154. GOINS EC, Wein LE, Watkins VY, Campbell AIK, et al
     Maternal and neonatal outcomes in patients with hepatitis C and intrahepatic cholestasis of pregnancy: The sum of the parts.
     PLoS One. 2023;18:e0293030.
     PubMed     Abstract available
     
     
     
155. HOOD RB, Miller WC, Shoben A, Harris RE, et al
     Maternal hepatitis C virus infection and three adverse maternal outcomes in the United States.
     PLoS One. 2023;18:e0291994.
     PubMed     Abstract available
     
     
     
156. BUTT AIK, Imran M, Aslam J, Batool S, et al
     Computational analysis of control of hepatitis B virus disease through vaccination and treatment strategies.
     PLoS One. 2023;18:e0288024.
     PubMed     Abstract available
     
     
     
157. GNANAPANDITHAN K, Ghali MP
     Self-awareness of hepatitis C infection in the United States: A cross-sectional study based on the National Health Nutrition and Examination Survey.
     PLoS One. 2023;18:e0293315.
     PubMed     Abstract available
     
     
     
158. ANGELO L, Vaillant A, Blanchet M, Labonte P, et al
     Pangenomic antiviral effect of REP 2139 in CRISPR/Cas9 engineered cell lines expressing hepatitis B virus surface antigen.
     PLoS One. 2023;18:e0293167.
     PubMed     Abstract available
     
     
     
159. NAQID IA, Mosa AA, Ibrahim SV, Ibrahim NH, et al
     Hepatitis B vaccination status and knowledge, attitude, and practice towards Hepatitis B virus among medical sciences students: A cross-sectional study.
     PLoS One. 2023;18:e0293822.
     PubMed     Abstract available
     
     
     
160. SAGOE KWC, Atuahene K, Ayiku ANA, Pappoe-Ashong PJ, et al
     Hepatitis B and human immunodeficiency virus infections within correctional facilities in Ghana.
     PLoS One. 2023;18:e0293009.
     PubMed     Abstract available
     
     
     
161. LANGAT BK, Ochwedo KO, Borlang J, Osiowy C, et al
     Genetic diversity, haplotype analysis, and prevalence of Hepatitis B virus MHR mutations among isolates from Kenyan blood donors.
     PLoS One. 2023;18:e0291378.
     PubMed     Abstract available
     
     
     
162. PRINSENBERG T, Illidge J, Zantkuijl P, Bedert M, et al
     Correction: Usability, acceptability, and self-reported impact of an innovative hepatitis C risk reduction intervention for men have sex with men: A mixed methods study.
     PLoS One. 2023;18:e0295455.
     PubMed     Abstract available
     
     
     
163. FONGWEN NT, Nchafack A, Rohan H, Ong JJ, et al
     Role and effectiveness of telephone hotlines in outbreak response in Africa: A systematic review and meta-analysis.
     PLoS One. 2023;18:e0292085.
     PubMed     Abstract available
     
     
     
164. QI M, Santos H, Pinheiro P, McGuinness DL, et al
     Demographic and socioeconomic determinants of access to care: A subgroup disparity analysis using new equity-focused measurements.
     PLoS One. 2023;18:e0290692.
     PubMed     Abstract available
     
     
     
165. KYEGOMBE N, Ajibola G, Sakoi-Mosetlhi M, Rebatenne T, et al
     Correction: Youth and healthcare workers' perspectives on the feasibility and acceptability of self-testing for HIV, Hepatitis and Syphilis among young people: Qualitative findings from a pilot study in Gaborone, Botswana.
     PLoS One. 2023;18:e0295779.
     PubMed     Abstract available
     
     
     
166. WANG B, Kaufmann B, Mogler C, Zhong S, et al
     Hepatocellular Brg1 promotes CCl4-induced liver inflammation, ECM accumulation and fibrosis in mice.
     PLoS One. 2023;18:e0294257.
     PubMed     Abstract available
     
     
     
167. ANWAR T, Ismail S, Parvaiz F, Abbasi SW, et al
     Computational design of experimentally validated multi-epitopes vaccine against hepatitis E virus: An immunological approach.
     PLoS One. 2023;18:e0294663.
     PubMed     Abstract available
     
     
     
168. YE J, Sun Y, Li J, Lu X, et al
     Distribution pattern, molecular transmission networks, and phylodynamic of hepatitis C virus in China.
     PLoS One. 2023;18:e0296053.
     PubMed     Abstract available
     
     
     
169. WURCEL AG, Guardado R, Grussing ED, Koutoujian PJ, et al
     Racial differences in testing for infectious diseases: An analysis of jail intake data.
     PLoS One. 2023;18:e0288254.
     PubMed     Abstract available
     
     
     
170. HOGAN S, Page A, Dixit S, McBride KA, et al
     HBV prevalence in Sub-continental countries: A systematic review and meta-analysis.
     PLoS One. 2023;18:e0295670.
     PubMed     Abstract available
     
     
     
171. ZHANG Y, Qu L, Pan Y, Wu Y, et al
     Predictive value of hepatitis B serological indicators for mortality among cancer survivors and validation in a gastric cancer cohort.
     PLoS One. 2023;18:e0286441.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge.